|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-11-16
|
|
pubmed:abstractText |
To evaluate the ability of diacerein, an interleukin-1beta inhibitor, to slow the progressive decrease in joint space width observed in patients with hip osteoarthritis (OA).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2539-47
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11710710-Anthraquinones,
pubmed-meshheading:11710710-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11710710-Digestive System Diseases,
pubmed-meshheading:11710710-Double-Blind Method,
pubmed-meshheading:11710710-Female,
pubmed-meshheading:11710710-Hip Joint,
pubmed-meshheading:11710710-Humans,
pubmed-meshheading:11710710-Male,
pubmed-meshheading:11710710-Middle Aged,
pubmed-meshheading:11710710-Osteoarthritis, Hip,
pubmed-meshheading:11710710-Pain,
pubmed-meshheading:11710710-Pain Measurement,
pubmed-meshheading:11710710-Severity of Illness Index,
pubmed-meshheading:11710710-Skin Diseases,
pubmed-meshheading:11710710-Treatment Outcome,
pubmed-meshheading:11710710-Urologic Diseases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.
|
|
pubmed:affiliation |
Université René Descartes and Hôpital Cochin, Service de Rhumatologie B, Paris, France. maxime.dougados@cch.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
